A detailed history of Wedmont Private Capital transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Wedmont Private Capital holds 1,477 shares of ALNY stock, worth $358,172. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,477
Previous 1,234 19.69%
Holding current value
$358,172
Previous $299,000 35.79%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$233.81 - $287.01 $56,815 - $69,743
243 Added 19.69%
1,477 $406,000
Q2 2024

Jul 15, 2024

BUY
$143.31 - $247.0 $176,844 - $304,798
1,234 New
1,234 $299,000
Q4 2022

Jan 09, 2023

BUY
$185.53 - $241.31 $171,986 - $223,694
927 New
927 $0

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.